NCT02243033View on ClinicalTrials.gov

Phase II Laser Focal Therapy of Prostate Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2036

Study Completion Date

November 30, 2036

Conditions
Prostate Cancer
Interventions
DEVICE

MR-guided laser focal therapy

Placement of laser applicator under MRI guidance and real-time MR thermal imaging of tissue necrosis.

Trial Locations (1)

92210

Desert Medical Imaging, Indian Wells

Sponsors

Lead Sponsor

HALO Diagnostics
All Listed Sponsors
lead

HALO Diagnostics

INDUSTRY

NCT02243033 - Phase II Laser Focal Therapy of Prostate Cancer | Biotech Hunter | Biotech Hunter